In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Playtex

This article was originally published in The Tan Sheet

Executive Summary

Playtex: Looking to broaden OTC/H&BA portfolio through brand or company acquisitions, or by leveraging the Playtex name on new products in different categories, the company says. Hass, Wheat & Partners, which holds a 40% stake in Playtex, also is investigating strategic options for the company. The decision to further diversify may in part be a response to Procter & Gamble's April 9 announcement that it will acquire tampon category leader Tambrands. Playtex already is making headway in diversifying its revenue base -- for the first quarter of 1997, sun care (Banana Boat and BioSun) sales jumped 32.4% to $43.7 mil., representing 32% of the company's sales of $136.4 mil. The feminine care unit, on the other hand, slumped 32.7% to $39.1 mil., accounting for 28.7% of sales. In the year-earlier quarter, the segments represented 23.1% and 40.6% of sales, respectively...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087100

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel